Translational Vision Science & Technology
ISSN 2164-2591 · Association for Research in Vision and Ophthalmology · United States · active 1961–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: gold. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Translational Vision Science & Technology a predatory journal?
Our screening does not flag Translational Vision Science & Technology. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in DOAJ, Scopus, Web of Science, PubMed, which is a positive signal.
Is Translational Vision Science & Technology indexed in Scopus or Web of Science?
Per our venue index, Translational Vision Science & Technology appears in: DOAJ, Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Translational Vision Science & Technology's impact?
Papers in Translational Vision Science & Technology are cited about 2.7 times each within two years of publication, and Scimago places it in Q1, with an h-index of 70. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Translational Vision Science & Technology open access?
Our index records its access status as "gold". Where this is derived from publisher-level signals rather than works-level data it is a heuristic, so confirm on the journal's own site — particularly if an article processing charge matters to you.
Similar venues
- Progress in Retinal and Eye ResearchQ1 · Elsevier BV
- Asia-Pacific Journal of OphthalmologyQ1 · Lippincott Williams & Wilkins
- Seminars in OphthalmologyQ1 · Taylor & Francis
- Survey of OphthalmologyQ1 · Elsevier BV
- Expert Opinion on Emerging DrugsQ2 · Taylor & Francis
- JAMA OphthalmologyQ1 · American Medical Association